NysnoBio

NysnoBio is a biopharmaceutical company developing a series of gene therapy product candidates aimed at addressing critical unmet medical needs in neurodegenerative diseases. NysnoBio focuses on highly validated therapeutic targets based on human genetics, pathology, and patient phenotypes. Meanwhile, NysnoBio's innovative clinical biomarker program provides strong efficacy markers for clinical use.